The Oncology Centre Research Unit, managed by a Head, Supervisor and support staff, comprises of three sub-units which offer unique services relevant to each area.

  • Clinical Research
  • Tumor Registry
  • Progenitor Stem Cell Transplant Program (PSCTP)

Clinical Research section is responsible for assisting Oncology Centre physicians and authorized others with the design of clinical research projects including the development of the database, data collection, data management and analysis of clinical data in accordance with Research Advisory Council guidelines.

      The Clinical Research Area offers the following services:

  • Actively participate in the coordination of in-house and international trials following Research Advisory
    Council guidelines.
  • Identify data elements for clinical research studies.
  • Design or assist with design of the Clinical Research Form.
  • Develop appropriate database for clinical research project.
  • Identify patients for inclusion into the clinical research study and request medical records.
  • Abstract pertinent data for entry into the database.
  • Provide specific descriptive epidemiology of cancer disease.
  • Perform data survival analysis.
  • Provide graphic presentation of data.
  • Assist with proposal development before submission to appropriate regulatory committees.

Tumor Registry is a pivotal function of the cancer program by providing definitive information concerning the nature and extent of the hospital’s experience in diagnosing and treating cancer. The Tumor Registry maintains a comprehensive database of all patients referred to King Faisal Specialist Hospital and Research Centre since 1975 with a malignant disease process, including cases seen at King Fahad National Children’s Cancer Centre. In addition, minimal information on neoplasms of uncertain behavior and benign brain tumors is abstracted from patient records and entered into the database. The Tumor Registry also produces an Annual Report for distribution throughout the hospital.

       Tumor Registry Annual Report:

       2013 Report

       The Tumor Registry offers the following services:

  • Identify patients with one or more malignant diagnoses.
  • Differentiate between most common malignancies by site or histology.
  • On request, generate lists of specific cases by selected criteria (variables).
  • Provide treatment information for a particular diagnosis.
  • Produce statistical and/or descriptive information for cases using demographic factors.
  • Show trends of certain disease categories over a given period.

      Cancer Registery Staging Forms

Progenitor Stem Cell Transplant Program (PSCTP) is a vital section responsible for the accrual of patients to be included in the King Faisal Specialist Hospital and Research Centre’s Bone Marrow Transplant Program database. It reports the hospital’s cases to the International Bone Marrow Transplant Registry (CIBMTR) and European Society for Blood and Marrow Transplantation (EBMT).

      The Progenitor Stem Cell Transplant Program offers the following services:           

  • Registration of patients in the International Bone Marrow Transplant Program.
  • Identification of appropriate data elements for both allogeneic and autologous Progenitor Stem Cell Transplant Programs as requested.
  • Design and development of databases for Progenitor Stem Cell Transplant Programs
  • Preparation of approved treatment protocols.
  • Produce follow-up information on study patients.
  • Database management for procurement of protocol data as requested for use in local prospective and retrospective research studies.
  • Assist with development of clinical research proposals using RAC guidelines, before submission to appropriate regulatory committees.


Accreditations & Awards